Yazar "Ozguroglu, M." seçeneğine göre listele
Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Avelumab vs Docetaxel for Previously Treated Advanced NSCLC: Primary Analysis of the Phase 3 JAVELIN Lung 200 Trial(Elsevier Science Inc, 2018) Barlesi, F.; Vansteenkiste, J.; Spigel, D.; Ishii, H.; Garassino, M.; De Marinis, F.; Ozguroglu, M.; Szczesna, A.; Polychronis, A.; Uslu, R.; Krzakowski, M.; Lee, J.; Calabro, L.; Frontera, O.; Ellers-Lenz, B.; Bajars, M.; Ruisi, M.; Parki, K.Öğe An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting(Elsevier Sci Ltd, 2018) Cicin, I.; Oukkal, M.; Mahfouf, H.; Mezlini, A.; Larbaoui, B.; Slim, B. A.; Uslu, R.; Errihani, H.; Alsalef, K.; Belbaraka, R.; Ozguroglu, M.; Goktas, B.Öğe Phase II study of loading-dose ibandronate treatment in patients in breast cancer and bone metastases suffering from moderate to severe pain(Amer Soc Clinical Oncology, 2010) Dizdar, O.; Altundag, M. K.; Ozkok, S.; Ozsaran, Z.; Saip, P.; Eralp, Y.; Komurcu, S.; Kuzhan, O.; Ozguroglu, M.; Karahoca, M.
